<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "https://rcpp-ie.com/nlm/tax-treatment-NS0.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:tp="http://www.plazi.org/taxpub" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">143</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:892805cc-c5d0-571f-8841-3ba335035073</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">Review of Clinical Pharmacology and Pharmacokinetics – International Edition</journal-title>
        <abbrev-journal-title xml:lang="en">RCPP</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1011-6583</issn>
      <issn pub-type="epub">2945-1922</issn>
      <publisher>
        <publisher-name>PHARMAKON-Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.61873/XEYD8146</article-id>
      <article-id pub-id-type="publisher-id">34765</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Keynote Speech</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The translational aspects of glucocorticoid biorhythmicity in modern therapeutics</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Kalafatakis</surname>
            <given-names>Konstantinos</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>
        <addr-line content-type="verbatim">Faculty of Medicine &amp; Dentistry (Malta campus), Queen Mary University of London, Victoria, Malta</addr-line>
        <institution>Faculty of Medicine &amp; Dentistry (Malta campus), Queen Mary University of London</institution>
        <addr-line content-type="city">Victoria</addr-line>
        <country>Malta</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Academic editor: </p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2024</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>05</day>
        <month>05</month>
        <year>2024</year>
      </pub-date>
      <volume>38</volume>
      <issue>s2</issue>
      <fpage>19</fpage>
      <lpage>21</lpage>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/7D0B2074-C548-5552-9A5E-E46F37A19D40">7D0B2074-C548-5552-9A5E-E46F37A19D40</uri>
      <permissions>
        <copyright-statement>Konstantinos Kalafatakis</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>Abstract</label>
        <p>Glucocorticoids are a class of steroid hormones, vital for mammalian life. They have a plethora of biological effects, mainly supporting metabolic, cognitive, and immunological functions. The pharmacological use of glucocorticoids makes them one of the most frequently prescribed drugs across all continents, and in all types of forms. Nevertheless, a number of serious adverse effects accompany the prolonged treatment with high doses of glucocorticoids. Research developments over the last 20 years have gradually reshaped the way we think about glucocorticoid-based therapeutics. Aside their circadian rhythm and their delayed regulatory influence over an extensive number of sensitive genes, glucocorticoids also possess an underlying, ultradian rhythm, and also exert rapid, non-genomic effects. The notion that chronicity of glucocorticoid stimulation may differentially modulate the type of biological effects of the hormone brings various chronopharmacological concepts on the table of modern glucocorticoid-based therapeutics.</p>
      </abstract>
    </article-meta>
  </front>
</article>
